A comparison of the conformability of everolimus-eluting bioresorbable vascular scaffolds to metal platform coronary stents.
Josep Gomez-Lara, Hector M Garcia-Garcia, Yoshinobu Onuma, Scot Garg, Evelyn Regar, Bernard De Bruyne, Stefan Windecker, Dougal McClean, Leif Thuesen, Dariusz Dudek, Jacques Koolen, Robert Whitbourn, Pieter C Smits, Bernard Chevalier, Cécile Dorange, Susan Veldhof, Marie-Angèle Morel, Ton de Vries, John A Ormiston, Patrick W Serruys
JACC Cardiovascular Interventions | Published : 2010
OBJECTIVES: The aim of this study was to assess the differences in terms of curvature and angulation of the treated vessel after the deployment of either a metallic stent or a polymeric scaffold device. BACKGROUND: Conformability of metallic platform stents (MPS) is the major determinant of geometric changes in coronary arteries caused by the stent deployment. It is not known how bioresorbable polymeric devices perform in this setting. METHODS: This retrospective study compares 102 patients who received an MPS (Multi-link Vision or Xience V, Abbott Vascular, Santa Clara, California) in the SPIRIT FIRST and II trials with 89 patients treated with the Revision 1.1 everolimus-eluting bioresorba..View full abstract